Bozkurt, B. et al. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J. Card. Fail. 29, 1412–1451 (2023).
Article PubMed PubMed Central Google Scholar
Clark, K. A. A. et al. Trends in heart failure hospitalizations in the US from 2008 to 2018. J. Card. Fail. 28, 171–180 (2022).
Chioncel, O. et al. Acute heart failure congestion and perfusion status — impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur. J. Heart Fail. 21, 1338–1352 (2019).
Hollenberg, S. M. et al. 2019 ACC Expert Consensus Decision Pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 74, 1966–2011 (2019).
Heidenreich, P. A. et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, e263–e421 (2022).
Boorsma, E. M. et al. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. Nat. Rev. Cardiol. 17, 641–655 (2020).
McDonagh, T. A. et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 24, 4–131 (2022).
Ambrosy, A. P. et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur. Heart J. 34, 835–843 (2013).
Testani, J. M., Chen, J., McCauley, B. D., Kimmel, S. E. & Shannon, R. P. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122, 265–272 (2010).
Article PubMed PubMed Central Google Scholar
Girerd, N. et al. Integrative assessment of congestion in heart failure throughout the patient journey. JACC Heart Fail. 6, 273–285 (2018).
Testani, J. M. et al. Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment. Am. J. Med. 128, 776–783.e4 (2015).
Article PubMed PubMed Central Google Scholar
Cox, Z. L. & Testani, J. M. Loop diuretic resistance complicating acute heart failure. Heart Fail. Rev. 25, 133–145 (2020).
Felker, G. M., Ellison, D. H., Mullens, W., Cox, Z. L. & Testani, J. M. Diuretic therapy for patients with heart failure: JACC state-of-the-art review. J. Am. Coll. Cardiol. 75, 1178–1195 (2020).
Article CAS PubMed Google Scholar
Cox, Z. L. & Lenihan, D. J. Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy. J. Card. Fail. 20, 611–622 (2014).
Article CAS PubMed Google Scholar
Greene, S. J. et al. In-hospital therapy for heart failure with reduced ejection fraction in the United States. JACC Heart Fail. 8, 943–953 (2020).
Metra, M. et al. Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion: a post hoc analysis of the PROTECT Data. Circ. Heart Fail. 11, e004644 (2018).
Article CAS PubMed Google Scholar
Damman, K. et al. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur. Heart J. 35, 455–469 (2014).
Zheng, J. et al. Contemporary decongestion strategies in patients hospitalized for heart failure: a National Community-Based Cohort Study. JACC Heart Fail. 12, 1381–1392 (2024).
Article CAS PubMed Google Scholar
Zheng, J. et al. Inpatient use of guideline-directed medical therapy during heart failure hospitalizations among community-based health systems. JACC Heart Fail. 13, 43–54 (2025).
Article CAS PubMed Google Scholar
Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 287, 1531–1540 (2002).
Mebazaa, A. et al. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur. Heart J. 31, 832–841 (2010).
Mullens, W. et al. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 21, 137–155 (2019).
Gheorghiade, M. et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur. J. Heart Fail. 12, 423–433 (2010).
Stevenson, L. W. & Perloff, J. K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261, 884–888 (1989).
Article CAS PubMed Google Scholar
Drazner, M. H. et al. Value of clinician assessment of hemodynamics in advanced heart failure: the ESCAPE trial. Circ. Heart Fail. 1, 170–177 (2008).
Article PubMed PubMed Central Google Scholar
Elder, A., Japp, A. & Verghese, A. How valuable is physical examination of the cardiovascular system? BMJ 354, i3309 (2016).
Chakko, S. et al. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am. J. Med. 90, 353–359 (1991).
Article CAS PubMed Google Scholar
Binanay, C. et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294, 1625–1633 (2005).
Stienen, S. et al. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-guided therapy in acute decompensated heart failure: PRIMA II randomized controlled trial (can NT-ProBNP-guided therapy during hospital admission for acute decompensated heart failure reduce mortality and readmissions?). Circulation 137, 1671–1683 (2018).
Article CAS PubMed Google Scholar
Lala, A. et al. Standardized definitions for evaluation of acute decompensated heart failure therapies: HF-ARC expert panel paper. JACC Heart Fail. 12, 1–15 (2024).
Article CAS PubMed Google Scholar
Georges, G., Fudim, M., Burkhoff, D., Leon, M. & Genereux, P. Patient selection and end point definitions for decongestion studies in acute decompensated heart failure: part 2. J. Soc. Cardiovasc. Angiogr. Interv. 2, 101059 (2023).
PubMed PubMed Central Google Scholar
Felker, G. M. et al. Diuretic strategies in patients with acute decompensated heart failure. N. Engl. J. Med. 364, 797–805 (2011).
Article CAS PubMed PubMed Central Google Scholar
Bart, B. A. et al. Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J. Card. Fail. 18, 176–182 (2012).
Article PubMed PubMed Central Google Scholar
Mullens, W. et al. Acetazolamide in acute decompensated heart failure with volume overload. N. Engl. J. Med. 387, 1185–1195 (2022).
Comentários (0)